Clinical Trial Results TV
Dr Gibson discusses Rosiglitazone and MI, decline in DES used after COURAGE
Dr Gibson discusses Rosiglitazone and the risk of MI, and the decline in DES (Drug Eluting
Stents) used after COURAGE.

[ Download video ]

Video Statistics
5 out of 5

1 Star 2 Star 3 Star 4 Star 5 Star

click a star to vote
This submission has received 1 total votes.

These statistics are updated nightly. The last update ran on
06-30-2022 EST at 1 am.

Additional Files
Filename File Description Action
No additional files available

Comments [ login to comment ]
No comments have been submitted